Estimates of current capacity for diagnosing and implementation of new treatment Alzheimer's disease in Slovenia
{{output}}
Background: The limited efficacy of current symptomatic treatments for Alzheimer's disease (AD) leads many patients to forgo medical help. However, new disease-modifying treatments (DMTs), such as donanemab and lecanemab, show p... ...
